CapsoVision, Inc. operates as a commercial-stage medical technology company. It engages in the development of imaging and artificial intelligence (AI)
technologies that are deployed for endoscopy solutions to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. The firm developed capsule endoscope system, currently comprising the CapsoCam Plus single-use capsule and the CapsoCloud and CapsoView software, to panoramically visualize the small-bowel mucosa to investigate abnormalities such as obscure GI bleeding and Crohns disease. The company was founded by Kang-Huai Wang on August 1, 2005 and is headquartered in Saratoga, CA. The company trades on NASD exchange. The company headquarter is located in USA.
| Ticker | CV |
| Long Name | CapsoVision Inc |
| Short Name | CapsoVision |